This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Myostin Therapeutics Pty Ltd, Orico Limited, Ovita Limited. Active years: 2006-2012.
Company Filing History:
Years Active: 2006-2012
Title: The Innovations of Mridula Sharma
Introduction
Mridula Sharma is a prominent inventor based in Hamilton, New Zealand. She has made significant contributions to the field of biotechnology, particularly in the area of muscle strength enhancement. With a total of 3 patents to her name, her work has garnered attention for its potential applications in health and fitness.
Latest Patents
Among her latest patents are two notable inventions. The first is titled "Isolated polypeptides and methods of improving muscle strength." This invention involves an isolated recombinant polypeptide that exhibits myostatin antagonist activity. It comprises a C-terminally truncated mature myostatin peptide, with the truncation occurring at a position between amino acids 281 and 329, or a fragment, variant, or derivative thereof. The second patent, "Myostatin and mimetics thereof," relates to an isolated mimetic of functional myostatin. This mimetic includes part of the amino acid sequence of functional myostatin, enabling it to inhibit muscle growth.
Career Highlights
Throughout her career, Mridula has worked with several companies, including Orico Limited and Myostin Therapeutics Pty Ltd. Her innovative research and development efforts have positioned her as a key figure in her field.
Collaborations
Mridula has collaborated with notable individuals such as Ravi Kambadur and James Johnston Bass. These partnerships have further enhanced her research and contributed to her success as an inventor.
Conclusion
Mridula Sharma's contributions to biotechnology and her innovative patents reflect her dedication to improving muscle strength and health. Her work continues to inspire advancements in the field, showcasing the impact of her inventions on future research and applications.